Published in Langenbecks Arch Surg on July 23, 2014
Survival after Gastrectomy in Node-Negative Gastric Cancer: A Review and Meta-Analysis of Prognostic Factors. Med Sci Monit (2015) 0.75
Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China. Medicine (Baltimore) (2016) 0.75
The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients. Medicine (Baltimore) (2016) 0.75
Cancer statistics, 2004. CA Cancer J Clin (2004) 15.72
The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med (1985) 8.55
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer (1999) 6.76
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol (2010) 6.60
Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg (1998) 4.86
Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys (1982) 3.05
A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg (2010) 2.27
Prognostic factors and recurrence pattern in node-negative advanced gastric cancer. Eur J Surg Oncol (2012) 2.05
Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer (2008) 1.49
Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol (2005) 1.48
Biologic predictors of survival in node-negative gastric cancer. Ann Surg (2003) 1.37
Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol (2004) 1.24
Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One (2012) 1.20
Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg (2009) 1.13
Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol (2010) 1.11
Prognostic factors in patients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma. World J Gastroenterol (2006) 1.10
Lymph node dissection in curative gastrectomy for advanced gastric cancer. Int J Surg Oncol (2011) 1.06
The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol (2008) 1.04
Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol (2000) 1.02
Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer. J Surg Oncol (2009) 1.01
Surgical treatment and outcome for node-negative gastric cancer. Surgery (1997) 1.00
Survival predictors in patients with node-negative gastric carcinoma. J Gastroenterol Hepatol (2007) 0.99
Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection. Eur J Surg Oncol (2011) 0.99
Expression of estrogen receptors in gastric cancer and their clinical significance. J Surg Oncol (2012) 0.98
Prediction of recurrence in advanced gastric cancer patients after curative resection by gene expression profiling. Int J Cancer (2005) 0.97
Prognostic factors on overall survival in lymph node negative gastric cancer patients who underwent curative resection. J Gastric Cancer (2012) 0.94
Multivisceral resection for gastric cancer: a systematic review. Gastric Cancer (2011) 0.92
Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol (2008) 0.90
Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma. Int J Oncol (2007) 0.89
Significant prognostic factors in patients with node-negative gastric cancer. Int Surg (2000) 0.88
Prognostic factors in patients with node-negative gastric cancer: a single center experience from China. J Gastrointest Surg (2012) 0.86
Impact of clinical and pathohistological characteristics on the incidence of recurrence and survival in elderly patients with gastric cancer. World J Surg (2012) 0.85
Prognostic factors in patients with node-negative gastric cancer: an Indian experience. World J Surg Oncol (2011) 0.83
Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer. World J Gastroenterol (2009) 0.82
[Prospective multicenter trial of gastric cancer surgery--a contribution to clinical research on quality control]. Zentralbl Chir (2005) 0.78
Gastric cancer in Europe (Br J Surg 2008; 95: 406-408). Br J Surg (2008) 0.77
Gastric cancer: the French survey. Acta Gastroenterol Belg (2002) 0.75
[Prognostic factors in 138 patients with node-negative gastric cancer]. Zhonghua Wei Chang Wai Ke Za Zhi (2011) 0.75
[Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients]. Zhonghua Zhong Liu Za Zhi (2013) 0.75
Limberg Flap Is Rhombic, Not Rhomboid. Plast Reconstr Surg (2016) 2.56
Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med (2011) 2.30
Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock (2009) 1.82
Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9. Cardiovasc Res (2008) 1.80
Hepatic artery thrombosis after adult liver transplantation. Liver Transpl (2003) 1.74
Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury. Crit Care Med (2010) 1.73
The heme oxygenase-carbon monoxide system: regulation and role in stress response and organ failure. Intensive Care Med (2008) 1.68
The fibrin-derived peptide Bbeta15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury. Crit Care Med (2007) 1.61
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Diagnosis and treatment of arterial steal syndromes in liver transplant recipients. Liver Transpl (2003) 1.58
Hyperglycemia at admission to the intensive care unit is associated with elevated serum concentrations of interleukin-6 and reduced ex vivo secretion of tumor necrosis factor-alpha. Crit Care Med (2004) 1.55
Bbeta15-42 (FX06) reduces pulmonary, myocardial, liver, and small intestine damage in a pig model of hemorrhagic shock and reperfusion. Crit Care Med (2009) 1.54
Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg (2003) 1.48
Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. Hepat Mon (2012) 1.47
The delay of rearterialization after initial portal reperfusion in living donor liver transplantation significantly determines the development of microvascular graft dysfunction. J Hepatol (2004) 1.46
Toll-like receptor 2 signaling triggers fatal arrhythmias upon myocardial ischemia-reperfusion. Crit Care Med (2010) 1.45
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine. Oncotarget (2013) 1.44
Iron Parameters Determine the Prognosis of Critically Ill Patients. Crit Care Med (2016) 1.43
Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Med (2012) 1.41
Deep proteome coverage based on ribosome profiling aids mass spectrometry-based protein and peptide discovery and provides evidence of alternative translation products and near-cognate translation initiation events. Mol Cell Proteomics (2013) 1.33
Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes. PLoS Comput Biol (2012) 1.32
Donor evaluation, donor risks, donor outcome, and donor quality of life in adult-to-adult living donor liver transplantation. Liver Transpl (2002) 1.27
Readmission to a surgical intensive care unit: incidence, outcome and risk factors. Crit Care (2008) 1.20
Living donor right liver lobes: preoperative CT volumetric measurement for calculation of intraoperative weight and volume. Radiology (2006) 1.19
Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One (2013) 1.18
U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis. Exp Mol Med (2013) 1.17
miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J Hepatol (2012) 1.13
Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A) correlates with efficient lentivirus infection of monocytes. J Biol Chem (2010) 1.12
Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. Clin Chem (2007) 1.12
Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology (2002) 1.11
Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma. Int J Colorectal Dis (2012) 1.10
Epidemiology of and factors associated with end-of-life decisions in a surgical intensive care unit. Crit Care Med (2010) 1.10
Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts. Crit Care (2010) 1.08
Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc Natl Acad Sci U S A (2006) 1.08
Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS One (2012) 1.08
Hypothermia and postconditioning after cardiopulmonary resuscitation reduce cardiac dysfunction by modulating inflammation, apoptosis and remodeling. PLoS One (2009) 1.08
Clinical chemistry reference database for Wistar rats and C57/BL6 mice. Biol Chem (2007) 1.08
Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen. Epigenetics (2012) 1.07
Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact. Cell Commun Signal (2013) 1.06
Anemia and blood transfusion in a surgical intensive care unit. Crit Care (2010) 1.06
Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma. Int J Oncol (2006) 1.06
Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma. J Clin Pathol (2011) 1.06
CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up. Liver Transpl (2002) 1.05
Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology (2005) 1.03
Medical and surgical therapy of inflammatory bowel disease in the elderly - prospects and complications. J Crohns Colitis (2011) 1.03
Initial hepatic microcirculation correlates with early graft function in human orthotopic liver transplantation. Liver Transpl (2005) 1.02
Identification of specific protein markers in microdissected hepatocellular carcinoma. J Proteome Res (2007) 1.01
High C5a levels are associated with increased mortality in sepsis patients--no enhancing effect by actin-free Gc-globulin. Clin Biochem (2008) 1.01
Down-regulation of MTUS1 in human colon tumors. Oncol Rep (2010) 1.01
Semi-automated measurement of hyperdense, hypodense and heterogeneous hepatic metastasis on standard MDCT slices. Comparison of semi-automated and manual measurement of RECIST and WHO criteria. Eur Radiol (2008) 1.01
CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo. Respir Res (2007) 1.00
Activation of PPARalpha and PPARgamma reduces triacylglycerol synthesis in rat hepatoma cells by reduction of nuclear SREBP-1. Eur J Pharmacol (2009) 0.99
Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis. Liver Int (2011) 0.99
Electroanatomic reconstruction of the left atrium, pulmonary veins, and esophagus compared with the "true anatomy" on multislice computed tomography in patients undergoing catheter ablation of atrial fibrillation. Heart Rhythm (2006) 0.98
Compliance with hand hygiene on surgical, medical, and neurologic intensive care units: direct observation versus calculated disinfectant usage. Am J Infect Control (2009) 0.98
Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia. Biochem Biophys Res Commun (2011) 0.97
Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients. Crit Care Med (2014) 0.97
Impact of viral accessory proteins of SIVsmmPBj on early steps of infection of quiescent cells. Virology (2007) 0.97
E-cadherin is a ligand for integrin alpha2beta1. Matrix Biol (2002) 0.96
Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int (2014) 0.96
Bariatric surgery to treat obesity. Semin Nephrol (2013) 0.93
PKCδ-induced PU.1 phosphorylation promotes hematopoietic stem cell differentiation to dendritic cells. Stem Cells (2011) 0.93
Effects of cardiac surgery on hemostasis. Transfus Med Rev (2006) 0.93
Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion. Carcinogenesis (2009) 0.92
Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. Biochem J (2012) 0.92
New methods for clinical pathways-Business Process Modeling Notation (BPMN) and Tangible Business Process Modeling (t.BPM). Langenbecks Arch Surg (2012) 0.91
Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis. Liver Int (2008) 0.91
Mouse carnitine-acylcarnitine translocase (CACT) is transcriptionally regulated by PPARalpha and PPARdelta in liver cells. Biochim Biophys Acta (2009) 0.90
The minimal essential unit for cadherin-mediated intercellular adhesion comprises extracellular domains 1 and 2. J Biol Chem (2004) 0.90
Ruptured aneurysm of the ulnar artery in a woman with neurofibromatosis. J Vasc Surg (2009) 0.89
Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2. Biochem Pharmacol (2006) 0.89
PAR-type thrombin receptors in renal carcinoma cells: PAR1-mediated EGFR activation promotes cell migration. Oncol Rep (2006) 0.89
Non-curative gastric resection for patients with stage 4 gastric cancer--a single center experience and current review of literature. Langenbecks Arch Surg (2012) 0.89
Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation. J Clin Endocrinol Metab (2007) 0.89
Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature. Gastric Cancer (2011) 0.89
Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. Transplantation (2003) 0.88
Long-term results and prognostic factors after resection of hepatic and pulmonary metastases of colorectal cancer. Int J Colorectal Dis (2012) 0.88
Stable transduction of primary human monocytes by simian lentiviral vector PBj. Mol Ther (2005) 0.88
Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4. J Cell Physiol (2007) 0.88
The European hospital exemption clause-new option for gene therapy? Hum Gene Ther (2012) 0.88
Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells. Int J Mol Med (2010) 0.88
Percutaneous transluminal laser angioplasty versus balloon dilation for treatment of popliteal artery occlusions. J Endovasc Ther (2002) 0.87
Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis--a retrospective analysis. Ther Apher Dial (2009) 0.87
Association of a common TLR-6 polymorphism with coronary artery disease - implications for healthy ageing? Immun Ageing (2013) 0.87
Monocarboxylate transporter (MCT)-1 is up-regulated by PPARalpha. Biochim Biophys Acta (2008) 0.87
Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation. Am J Transplant (2004) 0.86
Effect of coronary collaterals on long-term prognosis in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction. Am J Cardiol (2010) 0.86
FTY720 treatment in the convalescence period improves functional recovery and reduces reactive astrogliosis in photothrombotic stroke. PLoS One (2013) 0.86
High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event. J Cancer Res Clin Oncol (2011) 0.86
Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1. Regul Pept (2005) 0.85